“…There were no significant differences identified for other maternal or pregnancy outcomes assessed, including preterm birth, stillbirth, maternal anemia in the third trimester, miscarriage, maternal mortality, perinatal mortality, neonatal mortality, or risk of delivery by caesarean section when MMS was compared with supplementation with iron or without folic acid. A summary of these analyses is presented in Table , alongside the results from the IPD meta‐analysis for comparison, which is discussed in more detail below . However, it should be noted that the IPD was based on voluntary participation of the trial's investigators and was primarily aimed at conducting subgroup analyses, while the Cochrane Review was focused on the overall effects of all available trials.…”